Filing Details

Accession Number:
0001213900-13-002092
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-30 08:14:40
Reporting Period:
2013-04-30
Filing Date:
2013-04-30
Accepted Time:
2013-04-30 08:14:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1393463 Dc Brands International Inc DCBR Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1505893 Bob Armstrong C/O Dc Brands International, Inc.,
1685 S. Colorado Blvd #S291
Denver CO 80222
Cfo And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-30 100,000,000 $0.00 100,000,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Convertible Debt Acquisiton 2013-04-30 0 $50,000.00 100,000,000 $50,000.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1 2014-04-29 2014-04-29 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 24 Direct
Series A Preferred Stock 91,111 Direct
Footnotes
  1. Convertible debt was purchased by Mr. Armstrong from an existing convertible debt holder of DC Brands. The purchase price was $100,000 and was paid with a one year non-recourse promissory note. The debt is convertible into 200,000,000 shares of $.001 par value common stock of DC Brands international. The promissory note is secured by the debt purchased and/or the common stock of DC Brands that the debt is converted into. On April 30, 2013 1/2 of the debt was converted by Mr. Armstrong providing him the 100,000,000 shares detailed in Table I. This leaves $50,000 of debt that can be converted into an additional 100,000,000 shares of common stock anytime in the next twelve months, detailed in Table II.